Regencell Bioscience
RGC
4.18
-0.18
-4.13%
Regencell Bioscience
US · RGC
#2393 by market cap
Listed 2021
4.18
-0.18
-4.13%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:34
About Regencell Bioscience
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
- Founded
- 2014
- CEO
- Mr. Yat-Gai Au
- Employees
- 10
- Headquarters
- Hong Kong,China, HK, China
- Fiscal year end
- 06-30
- Website
- regencellbioscience.com
Company profile
- Exchange
- US
- Symbol
- RGC
- Market-cap rank
- #2393
- Listing date
- 2021-07-16
- Market cap
- 2.07B
- Float cap
- 235.72M
- Shares out
- 495.88M
- Float shares
- 56.39M
Sectors & themes
Quote time 2026-11-20 19:34:41 · For reference only, not investment advice and not tailored to your situation.
Regencell Bioscience discussion 0 comments